HomeOXB • LON
add
Oxford BioMedica plc
Previous close
GBX 569.00
Day range
GBX 542.00 - GBX 560.00
Year range
GBX 232.50 - GBX 962.00
Market cap
671.62M GBP
Avg Volume
419.02K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 47.76M | 22.47% |
Operating expense | 20.93M | -0.25% |
Net income | -1.88M | 64.80% |
Net profit margin | -3.94 | 71.30% |
Earnings per share | — | — |
EBITDA | -2.06M | -184.23% |
Effective tax rate | 36.20% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 96.90M | 59.77% |
Total assets | 325.72M | 40.61% |
Total liabilities | 234.37M | 36.94% |
Total equity | 91.35M | — |
Shares outstanding | 120.75M | — |
Price to book | 7.49 | — |
Return on assets | -2.89% | — |
Return on capital | -3.93% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.88M | 64.80% |
Cash from operations | -1.56M | 72.77% |
Cash from investing | -2.74M | -231.56% |
Cash from financing | 26.21M | 862.37% |
Net change in cash | 21.50M | 307.17% |
Free cash flow | -1.40M | -220.21% |
About
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
Founded
1995
Website
Employees
977
